PE-22-28 10 mg

Steroids Peptide Hubs Peptide

$27.00

PE-22-28 8 mg – Peptide Hubs

PE-22-28 is a research peptide derived from the loop region of brain-derived neurotrophic factor (BDNF), designed to mimic its effects without the adverse side effects associated with full-length BDNF. It selectively targets TrkB receptors, promoting synaptic plasticity, neurogenesis, and resilience to stress. Peptide Hubs offers PE-22-28 in a 8 mg high-purity lyophilized format suitable for neurological and psychiatric research.

Mechanism of Action

PE-22-28 activates TrkB receptors in a manner similar to endogenous BDNF but avoids activation of the p75NTR receptor, which is linked to apoptosis. This selective targeting makes it ideal for studying mood regulation, anxiety, memory consolidation, and neuronal repair without risk of excitotoxicity. In preclinical trials, it demonstrated strong anxiolytic and antidepressant-like effects. A 2017 study confirmed its neurotrophic properties and potential applications in mood and neurodegeneration models.

Key Research Applications

BDNF pathway activation and TrkB receptor studies
Stress resilience and mood stabilization models
Cognitive enhancement and memory retention research
Neurodegeneration and neuroplasticity protocols

PE-22-28 is often combined with other central-acting peptides like N-Acetyl Semax Amidate or N-Acetyl Selank Amidate in cognitive and mood research. For mitochondrial synergy, Humanin or MOTS-c are commonly stacked. Neurorepair models frequently also use FOX04-DRI.

Dispatched within 24 hours in plain, discreet packaging.

Additional Information

Categories:

Steroids

Brand: Peptide Hubs

Manufacturer: Peptide Hubs

Dosage Info: <div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel"> <section class="tab-panel" id="panel-usage"> <h2>Dosage & Usage Guidelines</h2> <ul> <li><strong>Dosage:</strong> 1–3 mg per day</li> <li><strong>Route:</strong> Intranasal or subcutaneous</li> <li><strong>Cycle:</strong> 10–30 days in behavioral and cognitive protocols</li> </ul> <h3>Stacking Suggestions</h3> <ul> <li>N-Acetyl Semax Amidate – BDNF synergy</li> <li>Humanin – mitochondrial neuroprotection</li> <li>FOX04-DRI – senolytic cognitive repair</li> <li>MOTS-c – neuro-metabolic resilience</li> </ul> <h3>Safety & Legal Status</h3> <p>PE-22-28 is not FDA-approved and is offered exclusively for <strong>scientific and research use only</strong>. No androgenic, estrogenic, or hepatotoxic effects have been reported in animal studies. Researchers must ensure proper storage and compliance with local research regulations.</p> </section> </div>

Reviews:

(0 customer reviews)